Gamete Preservation

Gamete Preservation Market Outlook

The global gamete preservation market is projected to reach approximately USD 5.6 billion by 2035, growing at a CAGR of around 8.2% from 2025 to 2035. This significant growth is primarily driven by the increasing prevalence of infertility issues, advancements in reproductive technologies, and a growing demand for fertility preservation among cancer patients and individuals seeking to delay parenthood due to personal or professional reasons. Additionally, the rising awareness about assisted reproductive technologies and government initiatives promoting fertility treatments are expected to contribute to the market's expansion. Furthermore, continuous innovations in preservation techniques and growing numbers of fertility clinics worldwide are pivotal factors propelling the demand for gamete preservation services.

Growth Factor of the Market

Several factors are driving the growth of the gamete preservation market. One of the primary reasons is the increasing rate of infertility, which affects millions of couples globally. This trend has led to a heightened demand for assisted reproductive technologies (ART), making gamete preservation services essential. Additionally, societal changes, such as career-oriented lifestyles and later marriages, have prompted individuals to seek fertility preservation options to maintain reproductive potential. The rise in oncofertility treatments, aimed at preserving reproductive capabilities in cancer patients undergoing chemotherapy or radiation therapy, further enhances the market's growth. Furthermore, advancements in preservation techniques, including improved cryopreservation and vitrification methods, have increased the success rates of gamete preservation, attracting more patients. Lastly, the increasing accessibility of fertility clinics and cryobanks has made these services more available to a broader population, contributing to market expansion.

Key Highlights of the Market

• The global gamete preservation market is anticipated to reach USD 5.6 billion by 2035.
• The market is expected to exhibit a CAGR of 8.2% from 2025 to 2035.
• Rising infertility rates significantly influence market growth.
• Advancements in reproductive technologies enhance preservation success rates.
• Increased awareness and accessibility of fertility preservation services drive demand.

By Product Type

Sperm Preservation:

Sperm preservation is a crucial segment of the gamete preservation market, primarily utilized for men who face fertility challenges due to health conditions, aging, or lifestyle choices. The preservation process involves collecting semen and storing it using cryopreservation techniques, allowing sperm to be frozen and stored for extended periods. This segment has witnessed significant growth, driven by the rising number of fertility preservation requests from men, especially those undergoing cancer treatment or those wishing to delay parenthood. The continuous advancements in freezing techniques have further improved sperm viability post-thawing, thus enhancing the success rates of assisted reproductive technologies. Consequently, sperm preservation services are becoming increasingly popular in fertility clinics and cryobanks worldwide.

Egg Preservation:

Egg preservation has gained prominence due to societal shifts wherein more women are opting to delay childbirth until later in life for personal or professional reasons. The egg freezing process, known as oocyte cryopreservation, enables women to store their eggs for future use, thereby safeguarding their reproductive options. The segment's growth is propelled by advancements in freezing techniques, such as vitrification, which enhance the survival rates of thawed eggs. Additionally, the rising awareness of fertility preservation among women, coupled with increasing support from healthcare providers, has contributed to the increased demand for egg preservation services, making it a crucial aspect of the gamete preservation market.

Embryo Preservation:

Embryo preservation involves the freezing of embryos created through in vitro fertilization (IVF) and is a vital segment in the gamete preservation market. This method allows couples to store viable embryos for future implantation, significantly increasing the chances of successful pregnancy. The growth of this segment is primarily driven by the rising acceptance of IVF as a standard fertility treatment, along with the increased success rates associated with embryo freezing and thawing. Furthermore, advancements in embryo freezing protocols and the increasing number of fertility clinics offering these services have further propelled the demand for embryo preservation. As more couples seek advanced fertility treatments, the significance of embryo preservation continues to grow.

Ovarian Tissue Preservation:

Ovarian tissue preservation is an emerging segment within the gamete preservation market, primarily aimed at young women facing fertility threats due to cancer treatments or other medical conditions. This innovative technique involves the surgical removal and subsequent freezing of ovarian tissue, allowing for future fertility restoration through transplantation. The growing awareness of oncofertility and the need for effective fertility preservation options among cancer patients have significantly boosted the demand for ovarian tissue preservation services. As the medical community continues to explore this area, advancements in surgical techniques and tissue storage methods are expected to enhance the viability and success rates of this preservation method, thereby contributing to its market growth.

Testicular Tissue Preservation:

Testicular tissue preservation is a specialized segment focused on preserving testicular tissue for boys and men who may face infertility due to medical conditions or treatments. This method is particularly crucial for prepubescent boys undergoing treatments that could impact their fertility. The preservation process entails the removal and freezing of testicular tissue, which may later be used for fertility restoration. As awareness surrounding fertility preservation options for young males increases, so does the demand for testicular tissue preservation services. While this segment is still developing, ongoing research and advancements in reproductive technology are poised to enhance its viability and applications, ultimately driving its growth in the gamete preservation market.

By Application

Fertility Preservation:

The fertility preservation application segment is a significant driver of the gamete preservation market, allowing individuals who wish to delay parenthood or who face fertility threats due to medical conditions to safeguard their reproductive capabilities. As societal norms shift and more individuals prioritize their careers or personal lives before starting families, the demand for fertility preservation services has increased substantially. This segment encompasses various preservation techniques for both men and women, including sperm and egg freezing, which are integral to assisted reproductive technologies. Moreover, awareness campaigns and educational efforts by healthcare providers have contributed to the growing acceptance and demand for fertility preservation options among younger populations, further enhancing market growth.

Assisted Reproductive Technology:

Assisted reproductive technology (ART) represents a crucial application segment of the gamete preservation market, significantly impacting infertility treatments. ART encompasses various techniques, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and embryo transfer, all of which often rely on preserved gametes. The increasing prevalence of infertility issues globally and the rising acceptance of ART have led to a significant surge in demand for gamete preservation services. As the technology continues to advance and success rates improve, more couples are likely to turn to ART solutions, further driving the need for effective gamete preservation techniques, thus propelling market growth.

Oncofertility:

The oncofertility application segment focuses on preserving the reproductive capabilities of cancer patients before they undergo potentially fertility-damaging treatments like chemotherapy or radiation. This specialized field has gained significant attention and growth due to the increasing number of cancer diagnoses and the growing awareness of fertility preservation options among cancer patients. Various preservation techniques, including sperm, egg, and embryo freezing, are employed to enable patients to retain their reproductive potential. The rising number of oncology clinics and partnerships with fertility specialists has made oncofertility services more accessible, thereby contributing to the market's expansion in this critical area.

Research:

The research application segment of the gamete preservation market plays an essential role in advancing reproductive health and technology. Research initiatives often utilize preserved gametes for various studies, including developmental biology, genetics, and reproductive medicine. The demand for gamete preservation in research settings has grown alongside increased funding and interest in reproductive health research. This segment is vital for developing new techniques and therapies in fertility treatments, thereby contributing to innovations that improve gamete preservation methods. As research efforts expand and collaboration between research institutions and fertility clinics strengthens, the demand for gamete preservation in research applications is likely to continue its upward trajectory.

By Preservation Method

Cryopreservation:

Cryopreservation is the most widely used method for gamete preservation, involving the cooling of biological samples to sub-zero temperatures to halt cellular metabolism and preserve cellular integrity. This technique is crucial for sperm, egg, and embryo preservation, allowing for long-term storage without compromising viability. The effectiveness of cryopreservation techniques has significantly improved over the years, with advancements in freezing protocols and the introduction of cryoprotectants that enhance cell survival post-thawing. As a result, the adoption of cryopreservation methods is on the rise, driven by increasing awareness of fertility preservation options and the growing availability of fertility clinics and cryobanks offering such services.

Vitrification:

Vitrification is a modern preservation method that has gained popularity due to its ability to achieve higher survival rates compared to traditional freezing techniques. This process involves rapidly cooling the biological samples, turning them into a glass-like state, thus preventing the formation of ice crystals that can damage cells. Vitrification is particularly effective for oocyte and embryo preservation and has become the preferred method among fertility specialists. The growing acceptance of vitrification, paired with advancements in technology and techniques, has led to increased success rates in assisted reproductive procedures, significantly boosting the demand for this preservation method within the gamete preservation market.

Freezing:

Freezing is a fundamental preservation method utilized in gamete preservation, where biological samples are cooled to sub-zero temperatures for storage over extended periods. Although traditional freezing methods are still in use, they have been largely supplemented by more advanced techniques, such as vitrification, which offer better outcomes. The simplicity of freezing methodologies makes it accessible and widely adopted across fertility clinics and cryobanks, contributing to its continued relevance in the market. This method remains essential for patients seeking fertility preservation, particularly in cases involving sperm and embryos, where long-term storage is vital.

Slow Freezing:

Slow freezing is a preservation technique that involves gradually lowering the temperature of biological samples, allowing for better acclimatization and potentially reducing cellular damage from ice crystal formation. While it has been a traditional method for gamete preservation, slow freezing has been largely overshadowed by the advent of vitrification, which has demonstrated higher success rates. Nonetheless, slow freezing is still employed in certain circumstances due to its simplicity and established protocols. As the demand for gamete preservation grows, slow freezing may continue to play a role, particularly in facilities that have not yet transitioned to newer technologies.

Rapid Freezing:

Rapid freezing is a technique characterized by the quick cooling of biological samples to minimize ice crystal formation, thereby preserving cellular integrity. Though not as commonly utilized as vitrification, rapid freezing has shown promise in specific applications, particularly in sperm and embryo preservation. The increasing focus on optimizing preservation techniques may drive the adoption of rapid freezing, especially in clinics seeking to improve their success rates. As research continues to explore various preservation methods, rapid freezing may gain more traction within the gamete preservation market, offering additional options for fertility preservation.

By End User

Fertility Clinics:

Fertility clinics are significant end users of gamete preservation services, providing a wide range of fertility treatments and options for individuals and couples seeking assistance with reproduction. These clinics typically offer services such as sperm and egg freezing, embryo storage, and assisted reproductive technologies, making them crucial players in the gamete preservation market. As the demand for fertility treatments rises, driven by increasing infertility rates and changing societal norms, fertility clinics are likely to expand their offerings and invest in advanced preservation technologies. This growing demand creates opportunities for fertility clinics to enhance their services and attract a larger clientele, ultimately driving the market forward.

Hospitals:

Hospitals play an essential role in the gamete preservation market by providing fertility preservation services as part of their comprehensive reproductive health programs. Many hospitals have dedicated reproductive health departments or collaborate with fertility specialists to offer services such as sperm and egg freezing for patients undergoing medical treatments that may impact their fertility. The increasing recognition of fertility preservation for cancer patients and individuals facing infertility challenges has led to greater integration of these services within hospitals. As awareness continues to grow, hospitals are likely to expand their capabilities and enhance their partnerships with fertility clinics, further driving the demand for gamete preservation services.

Cryobanks:

Cryobanks are specialized facilities dedicated to the storage and preservation of biological samples, including sperm, eggs, and embryos. They serve as critical suppliers in the gamete preservation market, providing long-term storage solutions for individuals and couples seeking fertility preservation. As the demand for gamete preservation increases, cryobanks are expanding their services and investing in advanced technologies to improve storage conditions and sample viability. The collaboration between cryobanks and fertility clinics enhances accessibility and convenience for patients, contributing to the overall growth of the gamete preservation market as more individuals seek to safeguard their reproductive potential.

Research Institutes:

Research institutes play a pivotal role in the gamete preservation market by conducting vital studies on reproductive health, fertility preservation techniques, and advancements in assisted reproductive technologies. These institutions often collaborate with fertility clinics and healthcare providers to explore new methodologies and improve existing practices in gamete preservation. The increasing focus on reproductive health research, combined with rising funding for studies in this area, drives demand for preserved gametes in various research applications. As research continues to evolve, the partnership between research institutes and clinical practices is likely to enhance the overall understanding of gamete preservation and contribute to market growth.

Others:

This segment encompasses various other end users of gamete preservation services, including educational institutions, biobanks, and non-profit organizations focused on reproductive health. These entities may engage in research or offer educational resources related to gamete preservation, contributing to the overall awareness and acceptance of fertility preservation. As the market continues to expand, these additional end users play a vital role in promoting and supporting the various aspects of gamete preservation, driving further research and development in the field. The diverse landscape of stakeholders facilitates a holistic approach to understanding and addressing the needs of individuals seeking fertility preservation options.

By Region

The North American region dominates the global gamete preservation market, accounting for a significant share. This dominance can be attributed to the high prevalence of infertility, increasing awareness of fertility preservation options, and the presence of advanced healthcare infrastructure. The United States, in particular, exhibits a robust demand for assisted reproductive technologies, with numerous fertility clinics and cryobanks offering a wide range of services. The market in North America is projected to grow at a CAGR of approximately 8.5% from 2025 to 2035, driven by continuous advancements in reproductive health technologies and an increasing emphasis on fertility preservation among individuals and healthcare providers.

Europe follows closely behind North America, holding a substantial share of the gamete preservation market. Countries like the United Kingdom, Germany, and France are at the forefront of fertility preservation services, supported by an increasing number of fertility clinics and favorable government policies promoting reproductive health. The European market is expected to grow steadily, driven by rising awareness around fertility issues, an increase in the number of infertility treatments being sought, and advancements in preservation methods. As healthcare systems continue to integrate fertility preservation into their services, Europe is anticipated to witness significant growth in this sector, further contributing to the global market.

Opportunities

The gamete preservation market presents various opportunities for stakeholders, particularly in light of the increasing demand for fertility preservation services. One key opportunity lies in the development and implementation of innovative preservation technologies that enhance the success rates of stored gametes. As research continues to explore advanced methods, such as improved cryopreservation and vitrification techniques, companies that invest in these technologies are likely to gain a competitive advantage. Furthermore, the rising number of fertility clinics and cryobanks worldwide creates opportunities for partnerships and collaborations, enabling stakeholders to expand their reach and provide comprehensive services. Additionally, educational initiatives aimed at raising awareness of fertility preservation options can help drive demand, leading to further growth in the market.

Another area of opportunity is the potential to cater to specific demographics, such as cancer patients and individuals facing age-related fertility challenges. By focusing on tailored services for these segments, companies can address the unique needs of patients who may require specialized preservation options. Additionally, expanding services to countries with growing awareness of reproductive health can open new markets for gamete preservation providers. As global populations increasingly recognize the importance of fertility preservation, stakeholders in the gamete preservation market can leverage these opportunities to enhance their service offerings and promote widespread adoption of preservation techniques.

Threats

The gamete preservation market faces several threats that could impact its growth trajectory. One of the primary concerns is the ethical and regulatory challenges associated with gamete preservation and assisted reproductive technologies. As technologies advance, debates surrounding the ethical implications of gamete storage, particularly in relation to embryo use and manipulation, may lead to stricter regulations that could hinder market growth. Additionally, the high costs associated with fertility preservation services can pose a barrier for many individuals, limiting access for those who cannot afford these treatments. As economic conditions fluctuate, the reluctance to invest in fertility preservation may increase, posing a threat to market expansion.

Another potential threat stems from the competitive landscape, as the increasing number of fertility clinics and cryobanks can lead to market saturation. This heightened competition could result in price wars and reduced profit margins for service providers, making it increasingly challenging for smaller entities to survive. Furthermore, the rapid advancement of technology means that companies must continually innovate and adapt to maintain their market position. Failure to keep up with these changes can lead to obsolescence, threatening the sustainability of businesses within the gamete preservation market.

Competitor Outlook

• CooperSurgical, Inc.
• Vitrolife AB
• Ferring Pharmaceuticals
• IVF Technologies
• Cryoport, Inc.
• Reproductive Health Specialists
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Asensus Surgical, Inc.
• OvaScience, Inc.
• Genea Limited
• Irvine Scientific
• K-Block
• ReproTech, LLC
• Cell Safe Biosciences

The competitive landscape of the gamete preservation market is characterized by a mix of established players and emerging companies striving to capture market share. Major companies in this sector are increasingly focusing on strategic partnerships, acquisitions, and collaborations to enhance their service offerings and expand their geographical presence. Additionally, these companies are investing heavily in research and development to innovate and improve preservation methods, ensuring that they stay ahead of the competition. The growing emphasis on reproductive health and fertility preservation has led to intensified competition among service providers, pushing them to differentiate their offerings and enhance patient experiences.

CooperSurgical, Inc. is a leading player in the gamete preservation market, known for its comprehensive range of fertility solutions. The company focuses on developing innovative technologies and products to enhance reproductive health outcomes. Their commitment to research and development has positioned them as a key competitor in the space. Similarly, Vitrolife AB has garnered recognition for its high-quality products and services related to gamete preservation, including media for IVF procedures and cryopreservation solutions. The company's focus on quality and successful outcomes has allowed it to maintain a strong foothold in the market.

Thermo Fisher Scientific Inc. is another significant player, offering a wide array of reproductive health products, including cryopreservation systems and equipment designed for fertility clinics and laboratories. Their extensive product portfolio and commitment to innovation enable them to cater to the diverse needs of the gamete preservation market. In contrast, Ferring Pharmaceuticals focuses on providing solutions specifically tailored for fertility treatments, including gamete preservation services. Their dedication to enhancing patient care and outcomes has solidified their position in the industry, allowing them to compete effectively in the evolving landscape of reproductive health.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 K-Block
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Merck KGaA
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Vitrolife AB
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Genea Limited
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Cryoport, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 ReproTech, LLC
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 IVF Technologies
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 OvaScience, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Irvine Scientific
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 CooperSurgical, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Cell Safe Biosciences
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Asensus Surgical, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Ferring Pharmaceuticals
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Reproductive Health Specialists
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Gamete Preservation Market, By End User
    • 6.1.1 Fertility Clinics
    • 6.1.2 Hospitals
    • 6.1.3 Cryobanks
    • 6.1.4 Research Institutes
    • 6.1.5 Others
  • 6.2 Gamete Preservation Market, By Application
    • 6.2.1 Fertility Preservation
    • 6.2.2 Assisted Reproductive Technology
    • 6.2.3 Oncofertility
    • 6.2.4 Research
  • 6.3 Gamete Preservation Market, By Product Type
    • 6.3.1 Sperm Preservation
    • 6.3.2 Egg Preservation
    • 6.3.3 Embryo Preservation
    • 6.3.4 Ovarian Tissue Preservation
    • 6.3.5 Testicular Tissue Preservation
  • 6.4 Gamete Preservation Market, By Preservation Method
    • 6.4.1 Cryopreservation
    • 6.4.2 Vitrification
    • 6.4.3 Freezing
    • 6.4.4 Slow Freezing
    • 6.4.5 Rapid Freezing

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Gamete Preservation Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Gamete Preservation market is categorized based on

By Product Type

• Sperm Preservation
• Egg Preservation
• Embryo Preservation
• Ovarian Tissue Preservation
• Testicular Tissue Preservation

By Application

• Fertility Preservation
• Assisted Reproductive Technology
• Oncofertility
• Research

By Preservation Method

• Cryopreservation
• Vitrification
• Freezing
• Slow Freezing
• Rapid Freezing

By End User

• Fertility Clinics
• Hospitals
• Cryobanks
• Research Institutes
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• CooperSurgical, Inc.
• Vitrolife AB
• Ferring Pharmaceuticals
• IVF Technologies
• Cryoport, Inc.
• Reproductive Health Specialists
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Asensus Surgical, Inc.
• OvaScience, Inc.
• Genea Limited
• Irvine Scientific
• K-Block
• ReproTech, LLC
• Cell Safe Biosciences